In Re: Zofran (Ondansetron)Products Liability Litigation
Case Number:
1:15-md-02657
Court:
Nature of Suit:
Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability
Multi Party Litigation:
Multi-district Litigation
Judge:
Firms
- Anapol Weiss
- Arnold & Porter
- Ashcraft & Gerel
- Ashley Injury Lawyers
- Bailey & Greer
- Baron & Budd
- Beasley Allen
- Becker Law Office
- Bednarz & Bednarz
- Belt & Bruner
- Bernstein Liebhard
- Bird Law Group
- Bisnar Chase
- Bizer & DeReus
- Blizzard Greenberg
- Brisbee & Stockton
- BrownGreer PLC
- Bruera Law Firm
- Buxbaum Daue
- Cohen & Malad
- Cowper Law
- Curtis Law Group
- DiCello Levitt
- Donnelly Conroy
- Dowdy Cockerham
- Dunn Sheehan
- eDiscovery CoCounsel
- Edwards & Culver
- Eichen Crutchlow
- Engstrom Lipscomb
- Feldman Shepherd
- Gathings Law
- George & Farinas
- Goede DeBoest
- Goldman Scarlato
- Grant & Eisenhofer
- Greenberg Traurig
- Gurfein Douglas
- Hare Wynn
- Harness IP
- Harrelson Law Firm
- Haug Partners
- Helland Law Firm
- Helmsdale Law LLP
- Heninger Garrison
- Herman Herman & Katz
- Hissey Mulderig
- Holland & Hart
- Irwin Fritchie
- Jackson & Tucker
- Jenner Law
- Junell & Associates
- Justinian & Associates
- Kagan Law Firm
- Kelley & Ferraro
- Kelley Uustal
- Kenny & Kenny
- Kershaw Talley
- Kiernan Trebach
- Kreindler & Kreindler
- Langdon & Emison
- Law Offices of Arnold E. DiJoseph
- Lear Werts
- Levin Simes
- Lieff Cabraser
- Maher Law Firm
- Maynard Nexsen
- Meyers & Flowers
- Michael Brady Lynch Firm
- Morrow Morrow
- Motley Rice
- Murray Law Firm
- Nabers Law Firm
- Napoli Shkolnik
- Nixon Peabody
- O'Hara Law Firm
- O'Leary Shelton
- OnderLaw
- Parker Waichman
- Paul Knopf
- Peiffer Wolf
- Phillips Lytle
- Pittman Dutton
- Pogust Goodhead
- Power Rogers
- Quattlebaum Grooms
- Reich & Binstock
- Reiner Slaughter
- Remer & Georges-Pierre
- Rheingold Giuffra
- Robins Kaplan
- Rudolph Friedmann
- Saunders & Walker
- Schlesinger Law Offices
- Searcy Denney
- Seeger Weiss
- Sherman Silverstein
- Shook Hardy
- Silva & Silva
- Silva & Silva PA
- Simmons Hanly
- Skikos Crawford
- Smith Porsborg
- Snow Legal Group
- The Flood Law Firm
- The Myers Firm
- Thomas & Libowitz
- TorHoerman Law
- Tucker Ellis
- Van Wey Presby
- Ventura Law (Danbury, CT)
- Wagstaff & Cartmell
- Wagstaff Law Firm
- Ware Jackson Lee
- Williams & Connolly
- Zoll & Kranz
Companies
Sectors & Industries:
-
October 06, 2016
Familes Blast GSK's New Zofran Label Submission In MDL
Families in multidistrict litigation over GlaxoSmithKline's anti-nausea drug Zofran on Thursday told a Massachusetts federal court that a 2016 label update shows that it was, in fact, possible to show additional warnings on a previous label beyond what had been approved by regulators, contrary to the company's assertions.
-
October 05, 2016
Parents Slam Bid To Toss GSK Zofran Suit From MDL
A set of parents in multidistrict litigation over GlaxoSmithKline’s anti-nausea drug Zofran struck back on Tuesday at a bid to include their suit in a consolidated dismissal motion, saying they’ve gone above and beyond to make sure certain of their documents were correctly filed.
-
February 22, 2016
GSK Wants To Know If MDL Plaintiffs Took Generic Zofran
GlaxoSmithKline urged a Massachusetts' federal court on Monday to require all plaintiffs in multidistrict litigation over anti-nausea drug Zofran to identify whether they used the brand-name drug or its generic equivalent, saying that doing so will allow the court to assess the viability of individual cases.
-
January 06, 2016
Families Say Animal Studies Back Their Claims In Zofran MDL
Families who claim that GlaxoSmithKline's "off label" promotion of its anti-nausea drug Zofran for morning sickness led to birth defects urged the Massachusetts federal judge overseeing the multidistrict litigation on Wednesday not to dismiss their claims, pointing to animal studies they say support their allegations.
-
October 13, 2015
JPML Consolidates Birth Defect Suits Over GSK's Zofran
The U.S. Judicial Panel on Multidistrict Litigation on Tuesday consolidated in Massachusetts district court a number of lawsuits alleging GlaxoSmithKline's "off label" promotion of its anti-nausea drug Zofran for morning sickness led to birth defects, saying five similar actions are pending in the court already, including the first-filed complaint.
- ← Previous
- 1
- 2
- 3
- 4
- 5
- Next →